A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia

Introduction: Treatment of relapsed and refractory (R/R) B acute lymphoblastic leukemia (B-ALL) represents an unmet medical need in children and adults. Adoptive T cells engineered to express a chimeric antigen receptor (CAR-T) is emerging as an effective technique for treating these patients. Areas...

Descripción completa

Detalles Bibliográficos
Autores principales: Martino, Massimo, Alati, Caterina, Canale, Filippo Antonio, Musuraca, Gerardo, Martinelli, Giovanni, Cerchione, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926700/
https://www.ncbi.nlm.nih.gov/pubmed/33670075
http://dx.doi.org/10.3390/ijms22042150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926700/
https://www.ncbi.nlm.nih.gov/pubmed/33670075
http://dx.doi.org/10.3390/ijms22042150

Ejemplares similares